CLINICAL MATERIAL
there were 107 cases of Grade 1 and 2 supratentorial astrocytomas, along with 13 brain stem gliomas, 9 cerebellar astrocytomas and 3 astrocytomas occurring in the spinal cord. During the same time there were 248 supratentorial Grades 3 and 4 astrocytomas. By pathologic classification for all astrocytomas in Alberta, 1960-70, the percentages were Grade 1 -8%, 2 -24%, 3 -39%, 4 -27%, unspecified -3%; by location they were: cerebral -88%, brain stem -5%, cerebellar -2%, spinal cord -0%, unspecified -4% (to the nearest %). Only the Grade 1 and 2 supratentorial astrocytomas were analyzed in detail.
The clinical information coded for computer analysis included the year of diagnosis, the surgeon, the patient's sex, age, duration of preoperative symptoms, postoperative survival in months, the presence or absence of headaches preoperatively, the estimated tumor size in centimeters based on the diagnostic studies, the type of diagnostic contrast study, the amount of midline shift in millimeters, the clinical group of the patient on admission preoperatively, the surgeon's estimate of the amount of tumor removal, the grade of pathology (1 or 2), steriod therapy (yes or no), and radiation therapy (yes or no).
RESULTS OF ANALYSIS

General
Nine neurosurgeons operated on 107 patients: 33% of patients had needle biopsy, 46% subtotal removals, 18% total removal, and 3% unknown. Radiation therapy was car-THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES ried out in 71% of patients and omitted in 29%. In 23% the astrocytomas were classified as Grade 1 and in 77% as Grade 2. Sixteen percent of the patients survived less than one month postoperatively. Fifty-eight percent survived longer than one year. In 32% of patients, the preoperative symptoms were less than one month in duration, whereas in 28% of patients they were longer than one year. At operation 23% of the patients had no neurologic deficit: clinical grade 0, 64% had neurologic deficit: clinical grade 1, and 13% had a neurological deficit plus depression of consciousness: clinical grade 2. Twelve patients lived longer than 84 months (11%) and five patients were lost to follow-up. Eleven patients on second operative procedures were diagnosed as having grades 3 or 4 astrocytoma on the second biopsy specimen. The average survival for astrocytomas, Grade 1, was 52±39 months, for the Grade 2 astrocytomas it was 30 i 34 months.
Statistical Analysis
A chi square analysis was carried out relating each of the measured variables. Strong associations (p < .001) existed between duration of postoperative survival and both radiation therapy and age. Table 1 lists significant associations (p <-05).
The average survival was 33 months, with a standard deviation of 36 months (Table 2 ). In the earlier study of grade 3 and 4 astrocytomas (n = 248) the average survival time was 6.6 months having a standard deviation of 8.1 months (Weir, 1973) . Table 2 also documents the number of cases and postoperative survival time by clinical grades for irradiated and non-irradiated groups.
The relationship of the extent of removal to postoperative survival is given in Figure I . It is interesting that the percent survival is greater for sub-total than total removal for the first 9 months, but following that, the percent is greater for total than sub-total, which in turn is greater than for needle biopsy. The additional analysis of the extent of removal curves against the use of radiation postoperatively (Figure 2 ) indicates that the use of radiation therapy is more important than the extent of surgical removal. However, these distinctions become relatively trivial after 3 years. Figure 3 shows the percent of survival over the months of survival for each of the three clinical grades. For long term survivors (more than 60 months) the clinical grades tend to converge. A further breakdown of the curves in Figure 3 into those who did or did not receive radiation appears in Figure 4 . For the long term survivors there was no significant difference between those radiated and not irradiated, except for Grade 2 where those not irradiated survived on the average less than one month.
A multiple regression equation was fitted with postoperative duration of survival as the predicted variable using the independent variables of age, radiation therapy, size of removal and clinical grade at surgery. The other variables were eliminated because of partial correlations with postoperative survival that were not significant.
Age showed the strongest measure of association with duration of postoperative survival, and as such, was the leading factor in predicting postoperative survival by contributing 29.2% to the variance. Clinical grade In Figures 5 and 6 the postoperative duration of survival is plotted against age with and without radiation. Figure 6 Weir and Grace FEBRUARY 1976 -49 DISCUSSION This series is unique in that all cases in a given area and time were included. Postoperative deaths were not excluded and few cases were lost to follow-up. This would explain some of the discrepancies in survival data compared to other series of low grade astrocytomas (Cushing, 1932; Gol, 1961; Levy and Elvidge, 1956 ). There would also be a variation in standards of pathologic classification.
The 16% postoperative (1 month) mortality is dismaying considering the fact that these patients had low grade astrocytomas at surgery. This probably reflects the fact that some more malignant tumors were included because the surgical specimen consisted only of tissue of a lower histologic grade. These patients then might not have had autopsy and so remained classified as a lower grade astrocytoma. Despite the fact that these tumors were low grade, 14 of the patients came to surgery with some degree of impairment of consciousness probably reflecting a large intracranial mass. The mortality in this series, however, is comparable to that of the previous major series. Levy and Elvidge (1956 ) had a 13% postoperative mortality in 113 operated cerebral astrocytomas. Gol (1961) had a total case mortality of 27% in 194 histologically confirmed low grade astrocytomas; in that series the mortality for a resection was 16% and for a biopsy, 37%. In Cushing's (1932) 164 cerebral astrocytomas, only 149 were operated and the case mortality was 15.4% of the operated cases. Ley et al. (1962) had a 16.2% postoperative mortality for cerebral astrocytomas. It is not possible to accurately compare these series because of the previous tendency to classify death occurring in hospital, regardless of time following surgery, as postoperative deaths. This is a less accurate method than specifying time. Factors other than the neurosurgical would come into play such as the ease of transferring patients to other facilities. With improvements in anesthesia, radiology and internal medicine current mortality can be expected to be reduced. Weir (1975) had a zero postoperative (within 30 days) mortality in 27 Grade 1 and 2 cerebral astrocytomas.
The initial 4 grade classification system from the Mayo group, as an accurate prognostic system, appears to have significant limitations. In the present series, the difference between Grade 1 (52 months) and Grade 2 (30 months) was not statistically significant. Similarly, Gol (1961) found no marked difference in survival between grades 1 and 2 (106 cases). Weir (1973) found almost no difference in survival between Grades 3 and 4 (248 cases). On the other hand, the difference between Grades 1 and 2 (33 months) and Grades 3 and 4 (7 months) is very impressive. The Mayo classification divides Grades 1 and 2 from 3 and 4 by the presence of mitotic figures. From the point of view of estimating an individual patient's prognosis, it is probably most useful to consider whether he has a low grade (amitotic, 1 or 2) or high grade (mitotic, 3 or 4) tumor. One is always left with the important limitation that the surgical specimen may not be from the most malignant portion of the tumor.
It is apparent from this analysis that age is the most important indicator of postoperative duration of survival. Although clinical grade does not have a significant association with survival (Table 1) in conjunction with age, the stepwise regression shows clinical grade to be the most important predictor from all the remaining variables. This contrasts with the relative importance of radiation therapy that was found in a larger number of Grade 3 and 4 astrocytomas. In the lower grade astrocytomas, the extent of surgical removal appears to be relatively more important than in the higher grade tumors. Gol (1961) found that "resection" was better than "biopsy", that young patients did exceptionally well and that radiated patients did slightly better than non-radiated patients.
In our patients who are still alive (4 -14 year survivors) and presumably have some type of superior biological immunity to their tumors, it does not seem to be important whether or not they received radiation therapy or whether or not they had large removals carried out.
In lower grade astrocytomas it appears that a more aggressive surgical and radiotherapeutic approach is indicated than for the higher grades of pathologic tumors. The ultimate outcome for the patient will depend most importantly however, on host defences to this neoplasm, rather than any therapeutic activity on the part of his physician.
